Is the Current Regulation of Autologous Stem Cells Appropriate?
By Dr. Ian Prosser -
Published 29 March 2017
This article discusses the regulation of autologous stem cells and tissue therapies in Australia by addressing issues such as the safety and efficacy of cell therapies, which therapies are regulated, what regulators are doing in other countries and "next steps" in cell and tissue regulation.
Categories: Features, Japan, Europe, Oceania, US, EMA, FDA, MHLW, PMDA, TGA, Human cell and tissue
Tags: Autologous Stem Cells